Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients With Qi-Yin Deficiency Syndrome During Chemotherapy: a Multicenter, Randomized, Prospective, Real-world Study

NCT04641819 is registered in ClinicalTrials.gov with ShuGuang Hospital as lead sponsor.

NCT NCT04641819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04641819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients With Qi-Yin Deficiency Syndrome During Chemotherapy: a Multicenter, Randomized, Prospective, Real-world Study
Lead sponsor
ShuGuang Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
April 27, 2021
Completion date
June 30, 2024
Enrollment
1,127 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, sleep disorder